1Al-Hajj M,Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci USA, 2003, 100(7): 3983-3988.
2Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/ progenitor cell properties [J]. Cancer Res, 2005, 65 (1): 5506-5511.
3Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy [J]. Breast Cancer Res, 2008, 10(2): R25.
4Polyak K. Breast cancer origins and evolution [J]. J Clin Invest, 2007, 117(11): 3155-3163.
5Molyneux G, Regan J, Smalley MJ. Mammary stem ceils and breast cancer [J]. Cell Mol Life Sci, 2007, 64 (24): 3248-3260.
6Sims AH, HOwell A, Howell SJ, et al. Origins of breast cancer subtypes and therapeutic implications [J]. Nat Clin Pract Oncol, 2007, 4(9): 516-525.
7Honeth G, Bendahl PO, Ringner M, et al. The CD44 +/ CD24- phenotype is enriched in basal-like breast tumors[J].Breast Cancer Res, 2008, 10(3): R53.
8Cariati M, Naderi A, Brown JP, et al. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line [J]. Int J Cancer, 2008, 122(2): 298-304.
5Reya T, Morrison S J, Clarke M F, et al. Stem cells, cancer, and cancer stem cells [ J ]. Nature, 2001,41 d ( 6859 ) : 105 - 111.
6Al-Hajj M, Wicha M S, Benito-Hemandez A, et al. Prospective identification of tumorigenic breast cancer cells [ J ]. Proc Natl Acad Sci U S A,2003,100(7) :3983 -3988.
7Smalley M, Ashworth A. Stem ceils and breast cancer: A field in transit[ J]. Nat Rev Cancer,2003,3 ( 11 ) :832 - 844.
8Al-Hajj M, Clarke M F. Self-renewal and solid tumor stem cells [ J ]. Oncogene ,2004,23 (43) :7274 - 7282.
9Ponti D,Costa A,Zaffaroni N,et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties [ J ]. Cancer Res,2005,65 ( 13 ) :5506 - 5511.
10Phillips T M, McBride W H, Pajonk F. The response of CD24 ^-/low/CD44^+ breast cancer-initiating cells to radiation [ J ]. J Natl Cancer Inst ,2006,98 (24) : 1777 - 1785.
1Kau P, Nagaraja GM, Zheng H, et al. A mouse model for triple- negative breast cancer tumor-initiating ceils (TNBC-T1Cs) exhibits similar aggressive phenotype to the human disease [ J ]. BMC Cancer, 2012, 12: 120.
2Rakha EA, Putti TC, Abd E1-Rehim DM, et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation [ J ]. J Pathol, 2006, 208 ( 4 ) : 495- 506.
3Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [ J ]. Nat Med, 1997, 3(7) : 730-737.
4Fillmore C, Kuperwasser C. Human breast cancer cell lines contain stem-like ceils that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy[ J]. Breast Cancer Res, 2008, 10(2) : R25.
5Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like ceils that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy[ J]. Breast Cancer Res, 2008, 10(2) : R25.
6Prud'homme GJ, Glinka Y, Toulina A, et al. Breast cancer stem- like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist [J]. PLoS One, 2010, 5(11): e13831.
7Brenton JD, Carey LA, Ahmed AA, et al. Molecular classification and molecular forecasting of breast cancer: Ready for clinical application [ J ] ? J Clin Oncol, 2005,23 (29) :7350 - 7360.
8Liu J, Lu KH, Liu Z1, et al. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1 [ J ]. BMC Cancer, 2012, 12: 519.
9Hu K, Law JH, Fotovati A, et al. Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor- initiating ceils [ J]. Breast Cancer Res, 2012, 14 : R22.
